Skin of color patients are less concerned that the cosmeceuticals they use address fine lines and wrinkles. Rather, they’re interested in products that minimize and treat hyperpigmentation from melasma or post-inflammatory hyperpigmentation, according to Susan C. Taylor, M.D., associate professor of Dermatology at the Perelman School of Medicine, Philadelphia, Penn.

Dr. Taylor presented “Skin of Color Cosmeceutical Considerations” during the Science of Cosmeceuticals and Nutraceuticals panel Sunday, March 3, at the 2019 American Academy of Dermatology Annual Meeting in Washington, DC.
Read more at Dermatology Times >>